Key result
An ovine model of NSTEMI created by multiple coronary ligations successfully reproduced clinical non-transmural infarcts, resulting in a 10% reduction in ejection fraction at 28 days and distinct extracellular matrix adverse remodeling.
Why the study?
The rising incidence and high mortality of NSTEMI represent an urgent clinical issue, but investigation of potential interventions lacks a reproducible pre-clinical model.
A novel ovine model of NSTEMI successfully reproduces specific extracellular matrix adverse remodeling, offering a reproducible platform for preclinical testing of targeted therapies.
Answers are grounded in this paper and cite their sources.
Ovine NSTEMI model enables preclinical therapy testing; leaves open human translation pending validation trials.
The rising incidence of non-ST-segment elevation myocardial infarction (NSTEMI) and associated long-term high mortality constitutes an urgent clinical issue. Unfortunately, the study of possible interventions to treat this pathology lacks a reproducible pre-clinical model. Indeed, currently adopted small and large animal models of MI mimic only full-thickness, ST-segment-elevation (STEMI) infarcts, and hence cater only for an investigation into therapeutics and interventions directed at this subset of MI. Thus, we develop an ovine model of NSTEMI by ligating the myocardial muscle at precise intervals parallel to the left anterior descending coronary artery. Upon histological and functional investigation to validate the proposed model and comparison with STEMI full ligation model, RNA-seq and proteomics show the distinctive features of post-NSTEMI tissue remodelling. Transcriptome and proteome-derived pathway analyses at acute (7 days) and late (28 days) post-NSTEMI pinpoint specific alterations in cardiac post-ischaemic extracellular matrix. Together with the rise of well-known markers of inflammation and fibrosis, NSTEMI ischaemic regions show distinctive patterns of complex galactosylated and sialylated N-glycans in cellular membranes and extracellular matrix. Identifying such changes in molecular moieties accessible to infusible and intra-myocardial injectable drugs sheds light on developing targeted pharmacological solutions to contrast adverse fibrotic remodelling.
No takes yet. Share an insight, caveat, or question.
Contessotto et al. (2023) studied Non-ST-segment elevation myocardial infarction (NSTEMI) (n=28). Multiple ligations parallel to the left anterior descending coronary artery (NSTEMI model) vs. Full-occlusion of the first diagonal branch (STEMI model) was evaluated on Reduction in ejection fraction (EF) at 28 days (p=0.009). An ovine model of NSTEMI created by multiple coronary ligations successfully reproduced clinical non-transmural infarcts, resulting in a 10% reduction in ejection fraction at 28 days and distinct extracellular matrix adverse remodeling.
Synapse has enriched 10 related papers. Consider them for comparative context: